Edition:
United Kingdom

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

4.02USD
6:19pm GMT
Change (% chg)

$0.02 (+0.50%)
Prev Close
$4.00
Open
$4.01
Day's High
$4.09
Day's Low
$3.97
Volume
33,146
Avg. Vol
124,083
52-wk High
$7.35
52-wk Low
$1.45

About

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its... (more)

Overall

Beta: --
Market Cap(Mil.): $96.98
Shares Outstanding(Mil.): 43.26
Dividend: --
Yield (%): --

Financials

  AFMD.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -0.99 -- --
ROI: -62.77 8.89 13.82
ROE: -67.79 10.02 15.24

Affimed puts on hold cancer drug trial after patient death

Oct 8 Drug developer Affimed N.V. on Monday put on hold the testing of its experimental cancer drug following the death of a patient and two life-threatening events.

08 Oct 2018

Earnings vs. Estimates